December 2017

News

December 4, 2017

Immunomic Therapeutics’ Founder Appointed to Maryland Life Sciences Advisory Board | Business Wire

Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company is pleased to announce Immunomic's…

Super User 0

Love0

News

December 4, 2017

Merck and Qiagen to expand in U.K.

U.S. drugmaker Merck & Co. and German diagnostics firm Qiagen are separately planning major investments…

Super User 0

Love0

News

December 4, 2017

DC Startup News: Tech Startup Funding, Investment in November

In covering the D.C. innovation economy comes the inevitable: funding news. Trust us, there’s a…

Super User 0

Love0

News

December 4, 2017

PhaseBio Enters Worldwide License Agreement with MedImmune for a Reversal Agent for Ticagrelor | Markets Insider

PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases,…

Super User 0

Love0

News

December 4, 2017

Mimetas OrganoPlate®

Complex tissues. Surprisingly simple. Enabling you to study complex 3D tissue biology in a simple…

Super User 0

Love0

News

December 4, 2017

Johns Hopkins researchers crack key part of mystery surrounding proteins

What makes the body of a person or any other organism work can for the…

Super User 0

Love0

News

December 4, 2017

Medical firm launches $10M venture capital fund | 2017-11-28 | Grand Rapids Business Journal

A medical device developer has created a $10-million venture capital fund to support early stage…

Super User 0

Love0

News

December 4, 2017

Avantor® Completes Acquisition of VWR

Avantor, Inc., a global supplier of ultra-high-purity materials for the life sciences and advanced technology…

Super User 0

Love0

News

December 4, 2017

Wharton and Angel Capital Association Study Changes Perceptions About the Investors Behind U.S. Startup Economy

The American Angel, a new comprehensive national study released today, provides a detailed picture of…

Super User 0

Love0

News

December 4, 2017

Roche launches HyperCap Target Enrichment Portfolio, a fully integrated and streamlined NGS sample

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the HyperCap Target Enrichment…

Super User 0

Love0

Immunomic Therapeutics’ Founder Appointed to Maryland Life Sciences Advisory Board | Business Wire

Merck and Qiagen to expand in U.K.

DC Startup News: Tech Startup Funding, Investment in November

PhaseBio Enters Worldwide License Agreement with MedImmune for a Reversal Agent for Ticagrelor | Markets Insider

Mimetas OrganoPlate®

Johns Hopkins researchers crack key part of mystery surrounding proteins

Medical firm launches $10M venture capital fund | 2017-11-28 | Grand Rapids Business Journal

Avantor® Completes Acquisition of VWR

Wharton and Angel Capital Association Study Changes Perceptions About the Investors Behind U.S. Startup Economy

Roche launches HyperCap Target Enrichment Portfolio, a fully integrated and streamlined NGS sample

About BioHealth Innovation

Contact

Connect